The Effects of ∆-9-THC and Naloxone in Humans | NCT01591629 | Trialant

The Effects of ∆-9-THC and Naloxone in Humans | NCT01591629 | Trialant

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Placebo and Placebo	Placebo Comparator		Drug: Placebo
Active Naloxone and Placebo	Experimental		Drug: Naloxone Drug: Placebo
Placebo and Active Delta-9-THC	Placebo Comparator		Drug: Delta-9-THC Drug: Placebo
Active Naloxone and Active Delta-9-THC	Experimental		Drug: Naloxone Drug: Delta-9-THC

Interventions

Name	Type	Description	Arm Group Labels	Other Names
Naloxone	Drug	Active Naloxone 18 mcg/kg intravenously over 60 minutes, 2mg IV push, 1mg IV push	Active Naloxone and Active Delta-9-THC Active Naloxone and Placebo

Outcomes Module

Secondary Outcomes

Measure	Description	Time Frame
Visual analog scales	Will assess subjective effects, perceptual alterations, and cognitive effects.	4 test days
Clinician Administered Dissociative States Scales (CADSS)	Will measure subjective effects, perceptual alterations, and cognitive effects.

Contacts/Locations Module

Condition Browse Module

Intervention Browse Module